Literature DB >> 17334612

From the behavioral pharmacology of beta-carbolines to seizures, anxiety, and memory.

Patrice Venault1, Georges Chapouthier.   

Abstract

A number of beta-carbolines are inverse agonists of the GABA-A receptor complex, acting on the benzodiazepine site. They show convulsive properties when administered at high doses, anxiogenic properties at moderate doses, and learning-enhancing effects at low doses. These data suggest a possible physiological relationship, through the GABA-A receptor channel, between memory processes, anxiety, and ultimately, in pathological states, epileptic seizures. This relationship seems to be confirmed partially by experiments on mouse strains selected for their resistance (BR) and sensitivity (BS) to a single convulsive dose of a beta-carboline. These two strains also show differences in anxiety and learning abilities. However, some opposite results found while observing the behavior of the two strains suggest that in addition to pharmacologically induced anxiety, there is spontaneous anxiety, no doubt involving other brain mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334612      PMCID: PMC5901106          DOI: 10.1100/tsw.2007.48

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  10 in total

1.  Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.

Authors:  Verónica Vidal; Susana García-Cerro; Paula Martínez; Andrea Corrales; Sara Lantigua; Rebeca Vidal; Noemí Rueda; Laurence Ozmen; Maria-Clemencia Hernández; Carmen Martínez-Cué
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

2.  Negative allosteric modulation of GABAA receptors inhibits facilitation of brain stimulation reward by drugs of abuse in C57BL6/J mice.

Authors:  Matthew E Tracy; Matthew L Banks; Keith L Shelton
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

Review 3.  GABA(A) receptor subtype-selective efficacy: TPA023, an alpha2/alpha3 selective non-sedating anxiolytic and alpha5IA, an alpha5 selective cognition enhancer.

Authors:  John R Atack
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

4.  Synthesis of aza and carbocyclic β-carbolines for the treatment of alcohol abuse. Regiospecific solution to the problem of 3,6-disubstituted β- and aza-β-carboline specificity.

Authors:  V V N Phani Babu Tiruveedhula; Kashi Reddy Methuku; Jeffrey R Deschamps; James M Cook
Journal:  Org Biomol Chem       Date:  2015-11-21       Impact factor: 3.876

5.  PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects.

Authors:  Ashenafi Mebratu Zewde; Frances Yu; Sunil Nayak; Christopher Tallarida; Allen B Reitz; Lynn G Kirby; Scott M Rawls
Journal:  J Neurosci Methods       Date:  2017-10-16       Impact factor: 2.390

6.  Chronic Treatment with a Promnesiant GABA-A α5-Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model.

Authors:  J Braudeau; L Dauphinot; A Duchon; A Loistron; R H Dodd; Y Hérault; B Delatour; M C Potier
Journal:  Adv Pharmacol Sci       Date:  2011-10-19

Review 7.  Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities.

Authors:  Noemí Rueda; Jesús Flórez; Carmen Martínez-Cué
Journal:  Neural Plast       Date:  2012-05-22       Impact factor: 3.599

8.  The Role of Hippocampal 5HT3 Receptors in Harmaline-Induced Memory Deficit.

Authors:  Mohammad Nasehi
Journal:  Basic Clin Neurosci       Date:  2015-07

9.  Effects of a Diet-Based Weight-Reducing Program with Probiotic Supplementation on Satiety Efficiency, Eating Behaviour Traits, and Psychosocial Behaviours in Obese Individuals.

Authors:  Marina Sanchez; Christian Darimont; Shirin Panahi; Vicky Drapeau; André Marette; Valerie H Taylor; Jean Doré; Angelo Tremblay
Journal:  Nutrients       Date:  2017-03-15       Impact factor: 5.717

Review 10.  The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization.

Authors:  Ede Frecska; Petra Bokor; Michael Winkelman
Journal:  Front Pharmacol       Date:  2016-03-02       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.